Evidence map›Paper›PMID 41836280›Full record

ArticleJAMIA open2026

Characterization and comparison of structured and unstructured electronic health record data mapped to MedDRA for post-marketing surveillance.

Joshua C Smith, Sharon E Davis, Ruth M Reeves, Robert Winter, Jill Whitaker, Daniel Park, Shirley V Wang, Massimiliano Russo, Judith C Maro, José J Hernández-Muñoz and 5 more

Abstract read
In one paragraph

Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Joshua C SmithDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID https://orcid.org/0000-0003-2661-3203
Sharon E DavisDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID https://orcid.org/0000-0003-0792-8867
Ruth M ReevesDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.
Robert WinterDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.
Jill WhitakerDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.
Daniel ParkDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.
Shirley V WangDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0001-7761-7090
Massimiliano RussoDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0003-4953-9341
Judith C MaroDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.ORCID https://orcid.org/0000-0001-9900-2142
José J Hernández-MuñozOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States.ORCID https://orcid.org/0000-0002-2553-3159
Yong MaOffice of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States.
Youjin WangOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States.
Jamal T JonesOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States.ORCID https://orcid.org/0000-0002-2709-0806
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Michael E MathenyDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
NICHD NIH HHS P50 HD103537
6 · The paper itself

Abstract

Objectives: Medical product safety surveillance efforts, whether using electronic health record (EHR) or claims data, typically rely on structured codes. Utilizing unstructured EHR data, particularly information extracted from clinical text through natural language processing (NLP), enriches information available for data mining, phenotyping, and surveillance. To assess overlapping and distinct information across structured and unstructured EHR data, we mapped both to a common vocabulary (Medical Dictionary for Regulatory Activities, MedDRA). We assess the feasibility of implementing such a mapping and explored similarities and differences at multiple levels of the concept hierarchy. Materials and Methods: We randomly sampled 15,000 encounters (5000 each from ambulatory, emergency, and inpatient encounters). For each encounter, we extracted MedDRA concepts from clinical notes using MetaMap and mapped structured ICD-10-CM diagnoses to MedDRA. We evaluated corroboration between data sources across the MedDRA hierarchy, as well as the unique information contributed by each source. Results: We processed 119,492 clinical notes and mapped 163,254 ICD-10-CM codes to MedDRA. Most encounters (73-98%) had some overlap between MedDRA preferred terms identified from structured and unstructured data. Among MedDRA concepts found in unstructured text, 80-95% were not found in the encounter's associated ICD-10-CM coded data. Discussion and Conclusion: While MedDRA concepts from structured data were mostly corroborated by those extracted from unstructured clinical text, the majority of MedDRA concepts recognized in each encounter were only mentioned in text. Leveraging MedDRA-encoded unstructured text can provide a more comprehensive clinical picture of patients and complement the structured data traditionally used in epidemiological and pharmacovigilance studies.

Indexed as

data miningelectronic health recordsinternational classification of diseasesnatural language processingpharmacovigilance

Identifiers

PMID41836280
PMCPMC12986765

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.